|
N-Methyl-4-pyridone-3-carboxamide
|
N1-甲基-4-吡啶酮-3-甲酰胺
|
769-49-3
|
|
Pantoprazole Impurity D
|
泮托拉唑相關(guān)物質(zhì)D和F混合物
|
624742-53-6
|
|
Nicotine Impurity C
|
煙堿雜質(zhì)C
|
|
|
Norethindrone 17-O-Glucuronide Sodium Salt
|
炔諾酮17 -O葡糖苷酸鈉鹽
|
|
|
Nilotinib Impurity 13
|
NILOTINIB IMPURITY 13
|
917391-28-7
|
|
Nintedanib Impurity G (Intedanib Impurity G)
|
尼達(dá)尼布雜質(zhì)G
|
|
|
Norethisterone Valerate
|
Norethisterone Valerate
|
112756-00-0
|
|
Nifurprazine
|
硝呋拉嗪
|
1614-20-6
|
|
Nicotinamide Adenine Dinucleotide-13C6,15N
|
|
|
|
Raloxifene Impurity C
|
雷洛昔芬雜質(zhì)C
|
195454-31-0
|
|
Pantoprazole Sulfide
|
泮托拉唑硫醚
|
102625-64-9
|
|
Nitrendipine Propyl Ester
|
尼群地平丙酯
|
225785-54-6
|
|
Pantoprazole Impurity (Mixture of Impurity D and F)
|
泮托拉唑雜質(zhì)
|
|
|
Nintedanib Impurity E (Intedanib Impurity E)
|
Nintedanib Impurity E (Intedanib Impurity E)
|
1610881-60-1
|
|
Norethisterone Hexanoate
|
炔諾酮雜質(zhì)31(己酸炔諾酮)
|
89094-33-7
|
|
Leflunomide
|
來氟米特
|
75706-12-6
|
|
Nimodipine
|
尼莫地平
|
66085-59-4
|
|
1-(2-Chloroethyl)piperidine hydrochloride
|
1-(2-氯乙基)哌啶鹽酸鹽
|
2008-75-5
|
|
Pantoprazole Sulfide Dimer
|
泮托拉唑硫醚二聚體雜質(zhì)
|
|
|
Teriflunomide impurity 1
|
特立氟胺雜質(zhì)
|
1385789-70-7
|
|
Nilotinib Impurity 1 HCl
|
尼羅替尼雜質(zhì)1 鹽酸鹽
|
|
|
Nimorazole
|
尼莫拉唑
|
6506-37-2
|
|
Pantoprazole Sulphone N-Oxide
|
泮托拉唑砜N-氧化物
|
953787-55-8
|
|
Nudifloramide
|
1-甲基-6-氧代吡啶-3-甲酰胺
|
701-44-0
|
|
17-epi-Norethindrone (Impurity G)
|
17表炔諾酮(與左炔諾孕酮雜質(zhì)K結(jié)構(gòu)式相同)
|
38673-36-8
|
|
Anabasine DiHCl
|
雙鹽酸假木賊堿
|
143924-48-5
|
|
Nintedanib Impurity 2 (Intedanib Impurity 2)
|
(3E)-1-(2-氯乙?；?-2,3-二氫-3-(甲氧基苯基亞甲基)-2-氧代-1H-吲哚-6-羧酸甲酯
|
1174335-83-1
|
|
Nilotinib Impurity 7
|
尼洛替尼EP雜質(zhì)E
|
2119583-26-3
|
|
Nintedanib Impurity 3 (Intedanib Impurity 3)
|
尼達(dá)尼布雜質(zhì)3
|
|
|
3-Pyridylacetic acid hydrochloride
|
吡啶-3-乙酸鹽酸鹽
|
6419-36-9
|
|
4-(Trifluoromethyl)aniline
|
對三氟甲基苯胺
|
455-14-1
|
|
O-Desmethyl Pantoprazole O-Sulfate
|
泮托拉唑雜質(zhì)1
|
1189856-53-8
|
|
Nicosulfuron
|
煙嘧磺隆
|
111991-09-4
|
|
Nilotinib N-Oxide
|
尼洛替尼N氧化物
|
1246817-85-5
|
|
Norethindrone Acetate Impurity D
|
醋酸炔諾酮雜質(zhì)D
|
|
|
Nicotinamide metabolite
|
煙酰胺代謝產(chǎn)物
|
|
|
Norethisterone 3-Hexenoate
|
|
|
|
Leflunomide Impurity G
|
|
|
|
Dehydro nisoldipine
|
脫氫尼索地平
|
103026-83-1
|
|
Leflunomide Impurity C
|
來氟米特雜質(zhì)C
|
61643-23-0
|
|
Raloxifene Impurity 3
|
2-[4-[(甲磺酰)氧]苯基]-苯并[B]噻吩-6-醇6-甲烷磺酸
|
84449-65-0
|
|
(R)-Pantoprazole
|
(R)-泮托拉唑
|
142706-18-1
|
|
N-Methyl-2-Pyridone 5-Carboxylic Acid
|
N-甲基2吡啶酮5羧基酸
|
|
|
Nilotinib Impurity 10
|
尼羅替尼雜質(zhì)10
|
|
|
Nintedanib Impurity 9 (Intedanib Impurity 9)
|
尼達(dá)尼布雜質(zhì)9
|
|
|
Nintedanib E-isomer (Intedanib E-isomer)
|
尼達(dá)尼布 E-異構(gòu)體(依替泰尼E-異構(gòu)體)
|
|
|
Nilotinib Impurity 2
|
尼洛替尼雜質(zhì)3
|
641571-06-4
|
|
Norethindrone Acetate EP Impurity D
|
醋酸炔諾酮EP雜質(zhì)D
|
|
|
(S)-(-)-Pantoprazole
|
泮托拉唑雜質(zhì)
|
142678-35-1
|
|
10-beta Hydroxy Norethindrone
|
10-Β羥基炔諾酮
|
1236-00-6
|
|
p-Nicorandil
|
P-尼可地爾
|
65141-47-1
|
|
Raloxifene Dimethoxy Impurity
|
雷洛昔芬二甲氧基雜質(zhì)
|
|
|
Raloxifene Impurity III
|
雷洛昔芬雜質(zhì) III
|
|
|
Nilotinib Impurity 8
|
尼羅替尼雜質(zhì)8
|
|
|
Nintedanib Impurity A (Intedanib Impurity A)
|
尼達(dá)尼布雜質(zhì)A
|
|
|
Nintedanib Impurity 7 (Intedanib Impurity 7)
|
尼達(dá)尼布雜質(zhì)7
|
|
|
Raloxifene-6-Glucuronide Lithium Salt
|
雷洛昔芬-6-葡萄糖醛酸苷
|
174264-50-7
|
|
Nicotinuric Acid
|
煙酰甘氨酸
|
583-08-4
|
|
Nicotine N-Oxide
|
尼古丁雜質(zhì)5
|
63551-14-4
|
|
Nilotinib Impurity 12
|
3-(4-甲基-1H-咪唑-1-基)-5-(三氟甲基)苯甲腈
|
641571-12-2
|
|
N-Methyl Nicotinamide
|
N-甲基煙酰胺
|
114-33-0
|
|
Nicorandil Impurity 3
|
吡啶, 3-(4,5-二氫-2-噁唑基)-
|
40055-37-6
|
|
Leflunomide Impurity F
|
來氟米特雜質(zhì)F
|
1403564-06-6
|
|
Nicorandil Impurity 2 Nitrate
|
尼可地爾雜質(zhì)2
|
88598-33-8
|
|
Pantoprazole Magnesium
|
泮托拉唑鎂
|
1022083-88-0
|
|
Nintedanib Impurity B (Intedanib Impurity B)
|
尼達(dá)尼布雜質(zhì)B(依替泰尼雜質(zhì)B)
|
|
|
Nintedanib Impurity H (Intedanib Impurity H)
|
尼達(dá)尼布雜質(zhì)H(依替泰尼雜質(zhì)H)
|
|
|
Teriflunomide-E Isomer
|
來氟米特雜質(zhì)12
|
214782-56-6
|
|
Pantoprazole N-Oxide
|
泮托拉唑N-氧化物
|
953787-60-5
|
|
N-Nitrosoanabasine
|
N-亞硝基新煙草堿
|
37620-20-5
|
|
Raloxifene EP Impurity A, N-oxide
|
|
|
|
Raloxifene Impurity 2
|
2-(4-羥基苯基)苯并[B]噻吩-6-醇
|
63676-22-2
|
|
5-Carboxy-6-Hydroxymethyl-Dehydronitrendipine
|
5-(Ethoxycarbonyl)-2-(hydroxyMethyl-6-Methyl-4-(3-nitrophenyl)nicotinic Acid
|
89267-43-6
|
|
Nilotinib Impurity 9
|
尼洛替尼雜質(zhì)9
|
641571-15-5
|
|
Pantoprazole Sulphone
|
泮托拉唑雜質(zhì)A
|
127780-16-9
|
|
Nintedanib Impurity 4 (Intedanib Impurity 4)
|
尼達(dá)尼布雜質(zhì)4
|
|
|
Nintedanib Impurity 1 (Intedanib Impurity 1)
|
尼達(dá)尼布雜質(zhì)1
|
|
|
5-(Difluoromethoxy)-2-mercapto-1H-benzimidazole
|
5-二氟甲氧基-2-巰基-1H-苯并咪唑
|
97963-62-7
|
|
Nilotinib Impurity 11
|
尼羅替尼雜質(zhì)11
|
2119583-24-1
|
|
Nilotinib Impurity 4
|
尼羅替尼雜質(zhì)4
|
|
|
Nicotinamide-N-oxide
|
N-氧代煙酰胺
|
1986-81-8
|
|
Nicosulfuron Impurity (DUDN)
|
|
|
|
Beta-Nicotyrine
|
二烯煙堿
|
487-19-4
|
|
Raloxifene-4',6-Diglucuronide Lithium Salt
|
RALOXIFENE-4',6-DIGLUCURONIDE LITHIUM SALT
|
|
|
Nilotinib Impurity 3
|
NILOTINIB IMPURITY 3
|
943320-48-7
|
|
Nintedanib Impurity 8 (Intedanib Impurity 8)
|
尼達(dá)尼布雜質(zhì)8(依替泰尼雜質(zhì)8)
|
|
|
Norethisterone Octoate
|
炔諾酮雜質(zhì)32(辛酸炔諾酮)
|
120793-85-3
|
|
Nifekalant HCl
|
鹽酸尼非卡蘭
|
130656-51-8
|
|
Pantoprazole Impurity 1
|
Pantoprazole Impurity 1
|
812664-93-0
|
|
Leflunomide Impurity D
|
5-甲基異惡唑-4-甲酸
|
42831-50-5
|
|
Raloxifene 4’-β-D-Glucuronide Lithium Salt
|
|
|
|
(1’S,2’S)-Nicotine 1’-Oxide
|
1'S,2'S)-尼古丁1'-氧化
|
51095-86-4
|
|
Nicotinic acid adenine dinucleotide sodium
|
DEAMIDO NAD SODIUM SALT
|
104809-30-5
|
|
Leflunomide Impurity H
|
氰基乙酰對三氟甲基苯胺
|
24522-30-3
|
|
Nilotinib Impurity 6
|
尼羅替尼雜質(zhì)6
|
|
|
Nintedanib Impurity C (Intedanib Impurity C)
|
尼達(dá)尼布雜質(zhì)C(依替泰尼雜質(zhì)C)
|
|
|
Nintedanib Impurity F (Intedanib Impurity F)
|
尼達(dá)尼布雜質(zhì)F(依替替尼雜質(zhì)F)
|
|
|
Nintedanib N-Glucuronide (Intedanib N-Glucuronide)
|
|
|
|
Benzyl nicotinate
|
煙酸芐酯
|
94-44-0
|
|
Ethyl 3-methylisoxazole-4-carboxylate
|
3-甲基異唑-4-甲酸乙酯
|
20328-15-8
|